Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00202800
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : June 4, 2013
Van Andel Research Institute
Eli Lilly and Company
Battle Creek Health System
Hackley Hospital
Metropolitan Hospital, Michigan
Mecosta County General Hospital
Munson Medical Center
Saint Mary's Health Care
Information provided by:
Spectrum Health Hospitals

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2007
  Actual Study Completion Date : January 2011